Harmony Biosciences Holdings (HRMY) Change in Cash (2019 - 2026)
Harmony Biosciences Holdings (HRMY) posted Change in Cash of -$163.1 million for Q1 2026, down 254.6% sequentially from $105.5 million in Q4 2025, and down 553.1% YoY from $36.0 million in Q1 2025.
Harmony Biosciences Holdings (HRMY) Change in Cash (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has reported Change in Cash for 8 years, with the latest figure at -$163.1 million in Q1 2026.
- Quarterly Change in Cash fell 553.1% year-over-year to -$163.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100.4 million (down 35.65% YoY) and the FY2025 annual result came in at $299.5 million, up 111.9% from the prior year.
- Change in Cash fell to -$163.1 million in Q1 2026 per HRMY's latest filing, from $105.5 million in the prior quarter.
- Over five years, Change in Cash peaked at $105.5 million in Q4 2025 and troughed at -$163.1 million in Q1 2026.
- A 5-year average of $20.9 million and a median of $24.8 million in 2022 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2024 and 2026: Change in Cash jumped 874.83% in 2024, then sank 553.1% in 2026.
- Over 5 years, Change in Cash stood at -$17.6 million in 2022, then increased by 26.4% to -$12.9 million in 2023, then soared by 607.89% to $65.6 million in 2024, then surged by 60.74% to $105.5 million in 2025, then slumped by 254.6% to -$163.1 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$163.1 million, $105.5 million, and $100.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn | -39.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -39.63 Mn |
| Mar 31, 2026 | -163.10 Mn |
| Dec 31, 2025 | 105.50 Mn |
| Sep 30, 2025 | 100.95 Mn |
| Jun 30, 2025 | 57.05 Mn |
| Mar 31, 2025 | 36.00 Mn |
| Dec 31, 2024 | 65.63 Mn |
| Sep 30, 2024 | 70.07 Mn |
| Jun 30, 2024 | -15.69 Mn |
| Mar 31, 2024 | 21.32 Mn |
| Dec 31, 2023 | -12.92 Mn |
| Sep 30, 2023 | 7.19 Mn |
| Jun 30, 2023 | 28.95 Mn |
| Mar 31, 2023 | 44.18 Mn |
| Dec 31, 2022 | -17.56 Mn |
| Sep 30, 2022 | 24.81 Mn |
| Jun 30, 2022 | 12.03 Mn |
| Mar 31, 2022 | -9.81 Mn |
| Dec 31, 2021 | 44.61 Mn |
| Sep 30, 2021 | 30.02 Mn |